Exchange: OTC·Updated 03:59 PM EDT

NWBO Northwest Biotherapeutics Inc

$0.1699
$0.0005
(0.29%)
Today
EarningsNov 12
Mkt Cap$288.94M
Vol1.45M

About NWBO

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.
42

Bearish Sentiment

How do you feel about NWBO?

Advertisement|Remove ads.